Importantly, across all AML subtypes according to the WHO classification, over 90% of AML cases displayed higher FBXL6 mRNA levels than healthy control bone marrow (Fig. 1G, Supplementary Fig. 1B). The gene discussed is FBXL6; the disease is acute myeloid leukemia.